Melissa Starovasnik
Director/Board Member at TWIST BIOSCIENCE CORPORATION
Net worth: 588 588 $ as of 31/03/2024
Profile
Melissa A.
Starovasnik is an Independent Director at Twist Bioscience Corp.
She previously worked as Vice President-Protein Sciences at Genentech, Inc. from 2011 to 2017.
She received her undergraduate degree in 1987 and her doctorate in 1992 from the University of Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TWIST BIOSCIENCE CORP.
0.03% | 06/02/2024 | 17,155 ( 0.03% ) | 588 588 $ | 31/03/2024 |
Melissa Starovasnik active positions
| Companies | Position | Start |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Director/Board Member | 06/08/2021 |
Former positions of Melissa Starovasnik
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2017 |
Training of Melissa Starovasnik
| University of Washington | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Melissa Starovasnik
